Kimball Electronics (NasdaqGS:KE) 2026 Conference Transcript

Kimball Electronics Conference Call Summary Company Overview - Company: Kimball Electronics (NasdaqGS:KE) - Industry: Electronics Manufacturing, specifically in automotive, industrial, and medical sectors - History: Established over 65 years ago, spun out from Kimball International 11 years ago to become a publicly traded company [2][3] Core Markets - Automotive: Focus on steering and braking systems - Industrial: Climate controls and off-highway equipment, referred to as the "green and clean" vertical - Medical: Full assembly of medical devices, including drug delivery systems and surgical instruments; recently opened a state-of-the-art CMO facility in Indianapolis [3][4][5] Strategic Focus - Shift to Healthcare: Two years ago, Kimball made a strategic decision to focus more on the healthcare sector, leveraging its electronics and plastics molding capabilities to enhance supply chain stickiness and improve positioning with customers [6][7] - Investment in Facilities: The company is investing in state-of-the-art facilities to support its medical strategy, including a new facility in Indianapolis with cold chain and cleanroom capabilities [8][48] Financial Performance - Q2 Results: Reported a 15% growth in the medical segment, with growth across all geographies and multiple programs; other segments, particularly automotive, faced challenges due to the loss of a large program [21][22][23] - Revenue Guidance: Raised revenue guidance for the full year to approximately $1.4 billion, driven by growth in the medical vertical [26][25] - Margin Improvement: Gross margin improved due to operational efficiencies and cost management, with adjusted operating income margins expected to rise from 4%-4.5% to potentially 6%-7% in the long term [27][56][59] Competitive Differentiation - Full Assembly Capability: Kimball offers full and final assembly for medical customers, which is attractive as many customers prefer to focus on R&D rather than manufacturing [17][18] - Unique Product Offerings: Examples include auto-injectors with integrated electronics that provide user prompts, showcasing vertical integration and innovation [19][20] Key Growth Areas - Drug Delivery Systems: Significant growth potential in the auto-injector market, particularly with the rise of GLP-1 medications; the company sees opportunities beyond current known drugs [38][39] - Microfluidics and Surgical Instruments: Interest in smaller, more efficient medical devices that require advanced manufacturing capabilities [40] Customer Relationships - Customer Concentration: Philips is a key customer, contributing over 10% of revenue through multiple divisions; Kimball aims to maintain long-term relationships and expand offerings to existing customers [42][44] - New Customer Acquisition: The goal is to add approximately five new customers annually to refresh the portfolio and drive growth [44] Facility Expansion - New Facility: The recently opened 300,000 sq ft facility in Indianapolis is designed to support growth and demonstrate capabilities to customers, with options for further expansion [48][49][50] M&A Strategy - Acquisition Criteria: Focus on expanding geographies and adjacencies that complement existing capabilities; looking for opportunities that enhance the portfolio and customer relationships [52][53] Conclusion - Long-term Outlook: The company is optimistic about achieving higher operating income margins and overall growth, driven by strategic investments in healthcare and operational efficiencies [56][59]